巴西 COVID-19 时代的癌症诊断。
Cancer diagnosis in Brazil in the COVID-19 era.
机构信息
University of Campinas, FOP-UNICAMP, São Paulo, Brazil.
Primary Care Postgraduate Program, State University of Montes Claros Unimontes, Minas Gerais, Brazil.
出版信息
Semin Oncol. 2021 Apr;48(2):156-159. doi: 10.1053/j.seminoncol.2020.12.002. Epub 2021 Jan 7.
The comprehensive care and treatment for cancer patients in Brazil, regulated by the National Cancer Prevention and Control Policy, is provided by Brazilian Unified Healthcare System (SUS) in certified health institution. Due the COVID-19 pandemic, several restrictive measures have been implemented by the State federation's governments, and cancer diagnosis reference centers were also impacted by these measures. Thus, this study aimed to compare SUS-oriented cancer diagnosis in Brazil before and during the pandemic so far. The average number of cancer diagnoses has dropped considerably in all Brazilian Regions since the pandemic period started. The number of new cancer cases has plunged in all regions, ranged from -24.3% in the North to -42.7% in Northeast region. The overall Brazilian average deficit reached 35.5%, corresponding to about 15,000 undiagnosed cases of cancer monthly. The pandemic period has dramatically reduced the diagnosis of new cases of cancer in Brazil, since consultations in public health services were compromised by restrictive measures. Therefore, effective measures must be urgently put in action in order to minimize the damage, and consequently, the negative health impacts caused by the COVID-19 pandemic in the care of cancer patients.
巴西的癌症患者综合护理和治疗由国家癌症预防和控制政策管理，在认证的卫生机构中由巴西统一医疗保健系统（SUS）提供。由于 COVID-19 大流行，州政府实施了多项限制措施，癌症诊断参考中心也受到了这些措施的影响。因此，本研究旨在比较大流行前后巴西 SUS 导向的癌症诊断。自大流行开始以来，巴西所有地区的癌症诊断数量都大幅下降。所有地区的新癌症病例数量都大幅下降，北部地区下降了 -24.3%，东北部地区下降了 -42.7%。巴西的总体平均赤字达到 35.5%，相当于每月约有 15000 例未确诊的癌症病例。由于限制措施影响了公共卫生服务中的咨询，大流行期间巴西新癌症病例的诊断急剧减少。因此，必须紧急采取有效措施，以尽量减少 COVID-19 大流行对癌症患者护理造成的损害和负面健康影响。
Zotero 插件